GlassScriptPhysician profile
Karissa B Hoeme
NPI 1144651696
$11,267.89
in general payments reported to CMS, 2019-2025
48 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,925 · 2022: $2,287 · 2023: $2,962 · 2024: $2,272 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,056.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,351.35 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbvie INC. | $1,860.46 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $908.14 | 2021-2025 | Xtampza, Belbuca, Nucynta |
| Scilex Pharmaceuticals INC. | $661.33 | 2021-2025 | Ztlido |
| Lundbeck LLC | $659.32 | 2021-2025 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $376.62 | 2021-2025 | Relistor |
| Saluda Medical Americas, INC. | $359.07 | 2024-2025 | Evoke |
| Biohaven Pharmaceuticals, INC. | $345.97 | 2021 | |
| Abbott Laboratories | $324.89 | 2023-2025 | Eterna, Proclaim |
| Amgen INC. | $275.04 | 2021-2022 | |
| Lilly USA, LLC | $272.44 | 2021-2025 | Reyvow, Emgality |
| Painteq LLC | $272.35 | 2023-2024 | Painteq |
| Pfizer INC. | $268.94 | 2023-2025 | |
| Averitas Pharma INC. | $247.12 | 2023-2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $221.27 | 2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $196.32 | 2022-2023 | Reactiv8 |
| Nalu Medical, INC. | $158.76 | 2021-2022 | |
| Vertos Medical, INC. | $138.11 | 2023 | Mild Device Kit |
| Ibsa Pharma INC. | $134.61 | 2021-2025 | Tirosint, Licart, Tirosint |
| Si-Bone, INC. | $122.64 | 2024 | |
| Radius Health, INC. | $91.52 | 2021-2025 | Tymlos |
| Grt US Holding, INC. | $90.82 | 2022 | |
| Medtronic, INC. | $77.23 | 2021-2023 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $72.41 | 2023-2024 | Sprint Pns System |
| Allergan, INC. | $71.99 | 2021-2022 | |
| Nevro Corp. | $67.79 | 2023-2024 | Senza |
| Horizon Therapeutics Plc | $66.05 | 2022 | |
| Tonix Medicines, INC. | $61.46 | 2025 | Tonmya |
| Supernus Pharmaceuticals, INC. | $59.98 | 2021-2022 | |
| Spinal Simplicity, LLC | $47.48 | 2022-2023 | Ha Minuteman G3-R |
| Upsher-Smith Laboratories LLC | $43.39 | 2021-2022 | |
| Axsome Therapeutics, INC. | $41.59 | 2025 | Symbravo |
| Idorsia Pharmaceuticals US INC | $35.24 | 2023-2024 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $34.49 | 2024-2025 | |
| Convatec INC. | $30.37 | 2024 | |
| Almatica Pharma LLC | $25.99 | 2021 | |
| Eisai INC. | $25.92 | 2021 | |
| Biodelivery Sciences International, INC. | $19.84 | 2021 | |
| Axonics, INC. | $19.42 | 2024 | Bulkamid, Axonics |
| Zimmer Biomet Holdings, INC. | $16.99 | 2024 | Gps III Platelet Concentration System |
| Merck Sharp & Dohme LLC | $16.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.34 | 2021 | |
| Curonix LLC | $14.82 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $14.42 | 2022 | |
| Bioventus LLC | $14.39 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.84 | 2022 | |
| Impel Pharmaceuticals INC. | $12.55 | 2022 | |
| Redhill Biopharma INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karissa Hoeme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.